NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Figure 1

RNA and protein expression level of NCOA4 in human pan-cancer. (a) The expression level of NCOA4 in different human cancer types from the TCGA database. The red and blue boxes represent tumor tissues and unpaired normal tissues, respectively. (b) The expression level of NCOA4 in different human cancer types from the TCGA database. The red and blue boxes represent tumor tissues and paired normal tissues, respectively. (c) NCOA4 expression levels in ACC, DLBC, LAML, LGG, OV, and UCS were not shown by TCGA, instead of the GTEx database. (d) The protein level of NCOA4 in normal and tumor tissues, such as breast cancer, ovarian cancer, clear cell RCC, UCEC, LUAD, HNSC, GBM, and hepatocellular carcinoma, was analyzed by the CPTAC dataset. (ns: ; ; ; ; ).

(a)

(b)

(c)

(d)